Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling
Authors:
- Stephanie I. BettinkSBStephanie I. Bettink
- Jan-Christian ReilJRJan-Christian Reil
- Andrey KazakovAKAndrey Kazakov
- Christina KörbelCKChristina Körbel
- Dominic MillenaarDMDominic Millenaar
- Ulrich LaufsULUlrich Laufs
- Bruno SchellerBSBruno Scheller
- Michael BöhmMBMichael Böhm
- Stephan H. SchirmerSSStephan H. Schirmer
Open Access
- 19 October 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (10) , 2636
Abstract
Pressure-overload-induced cardiac hypertrophy represents one cause of the development of heart failure. The aim of this study is to characterize the influence of the TIR-domain-containing adapter-inducing interferon-β (TRIF) during afterload-induced myocardial remodeling. After trans-aortic constriction (TAC), cardiac pressure overload leads to an early increase in MyD88- (Myeloid differentiation primary response gene 88) and TRIF-dependent cytokines. The maximum cytokine expression appeared within the first week and decreased to its control level within five weeks. While cardiomyocyte hypertrophy was comparable, the myocardial accumulation of the inflammatory cells was lower in TRIF−/−mice. At d7, TRIF deficiency reduced transcription factors and TRIF-dependent cytokines. Through the modulation of the TGF-β-signaling pathway and anti-fibrotic microRNAs, TRIF was involved in the development of interstitial fibrosis. The absence of TRIF was associated with a decreased expression of proapoptotic proteins. In echocardiography and working heart analyses, TRIF deficiency slowed left-ventricular wall thickening, myocardial hypertrophy, and reduces the ejection fraction. In summary, TRIF is an important adapter protein for the release of inflammatory cytokines and the accumulation of inflammatory cells in the early stage of maladaptive cardiac remodeling. TRIF is involved in the development of cardiac fibrosis by modulating inflammatory and fibrotic signal transduction pathways.Keywords
Funding Information
- German Research Foundation (DFG KFO 196, DFG TTR 219)
- HomFor (DFG KFO 196, DFG TTR 219)
This publication has 41 references indexed in Scilit:
- Role of Extracellular RNA and TLR3‐Trif Signaling in Myocardial Ischemia–Reperfusion InjuryJournal of the American Heart Association, 2014
- MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to CardiomyocytesCirculation Research, 2012
- MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2012
- The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancerJournal of Hematology & Oncology, 2012
- The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injuryPhysiological Genomics, 2012
- Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal FibrosisJournal of the American Society of Nephrology, 2012
- Transforming growth factor (TGF)-β signaling in cardiac remodelingJournal of Molecular and Cellular Cardiology, 2011
- Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the HeartTransplantation, 2009
- A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunityProceedings of the National Academy of Sciences, 2008
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008